Evidence map›Paper›PMID 41890810›Full record

ArticleBioinformatics advances2026

Sparse dimensionality reduction for analyzing single-cell-resolved interactions.

Niklas Brunn, Maren Hackenberg, Camila L Fullio, Tanja Vogel, Harald Binder

Abstract read
In one paragraph

Article in Bioinformatics advances, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Niklas BrunnInstitute of Medical Biometry and Statistics (IMBI), Faculty of Medicine and Medical Center, University of Freiburg, Freiburg im Breisgau 79104, Germany.ORCID https://orcid.org/0009-0006-8246-1549
Maren HackenbergInstitute of Medical Biometry and Statistics (IMBI), Faculty of Medicine and Medical Center, University of Freiburg, Freiburg im Breisgau 79104, Germany.ORCID https://orcid.org/0000-0003-4403-634X
Camila L FullioInstitute of Anatomy and Cell Biology, Department Molecular Embryology, Faculty of Medicine, University of Freiburg, Freiburg im Breisgau 79104, Germany.ORCID https://orcid.org/0000-0002-1061-8758
Tanja VogelInstitute of Anatomy and Cell Biology, Department Molecular Embryology, Faculty of Medicine, University of Freiburg, Freiburg im Breisgau 79104, Germany.ORCID https://orcid.org/0000-0002-0602-9133
Harald BinderInstitute of Medical Biometry and Statistics (IMBI), Faculty of Medicine and Medical Center, University of Freiburg, Freiburg im Breisgau 79104, Germany.ORCID https://orcid.org/0000-0002-5666-8662

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Summary: Several approaches have been proposed to reconstruct interactions between groups of cells or individual cells from single-cell transcriptomics data, leveraging prior information about known ligand-receptor interactions. To enhance downstream analyses, we present an end-to-end dimensionality reduction workflow, specifically tailored for single-cell cell-cell interaction data. In particular, we demonstrate that sparse dimensionality reduction can pinpoint specific ligand-receptor interactions in relation to clusters of cell pairs. For sparse dimensionality reduction, we focus on the Boosting Autoencoder approach. Overall, we provide a comprehensive workflow, including result visualization, that simplifies the analysis of interaction patterns in cell pairs. This is supported by a Jupyter notebook that can readily be adapted to different datasets. Availability and implementation: https://github.com/NiklasBrunn/Sparse-dimension-reduction.

Identifiers

PMID41890810
PMCPMC13014469

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.